ES
MARKETS / NYSE / NTR
NYSE · AGRICULTURAL CHEMICALS

Nutrien Ltd. NTR

9 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$26.9B
▲ 3.5% vs FY2024
Dividend streak
2 yrs
Raised every year since 2024
EPS · FY25
$4.66
Dividend / sh · FY25
—
Payout · FY25
47%
ROE · FY25
9.1%
Net margin · FY25
8.4%
Dividend coverage
0.6×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 26.9B
Revenue, FY2025 · full 9-year series below
Revenue Net income
1020304026.92.32017202020232025
1020304026.92.32017202020232025

8 cents of every revenue dollar became profit this year.

Per share
USD 4.66
Diluted EPS, FY2025
EPS Dividend
510154.662017202020232025
510154.662017202020232025

Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.

Profitability
9.1%
Return on equity, FY2025
ROE
81624329.1%2017202020232025
81624329.1%2017202020232025
Operating margin13.9%
Net margin8.4%
Return on assets4.4%

Each USD of equity produced 9 cents of profit this year.

Returned to shareholders
USD 1.6B
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 1.1B
Net buybacksUSD 551.0M
Share of profit71.1%
Consecutive raises2 years

USD 1.1B in dividends and USD 551.0M in buybacks — 71% of the year's profit went back to shareholders.

Growth
+5.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−10.8%
+5.2%
Net income
−33.4%
+37.6%
EPS, diluted
−31.0%
+41.9%
Returned to shareholders
−33.8%
+6.3%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
—
Shares outstanding, FY2025
0.610.492017202020232025
0.610.492017202020232025
Change, 5 years−14.3%
Change, 10 years—

The share count shrank 14% in five years — the same company, cut into fewer, larger slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 52.3B
total assets, end of FY2025
Total assetsUSD 52.3B
EquityUSD 25.3B
CashUSD 701.0M
Gross debtUSD 9.9B
Net debtUSD 9.2B
Current ratio1.34×

Net debt stands at 36% of equity.

History
9 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue $B
26.9
26.0
29.1
37.9
27.7
20.9
20.1
19.6
4.5
Operating income $B
3.7
1.9
2.7
10.8
4.8
0.9
1.9
0.4
0.2
EBITDA $B
6.1
4.2
4.9
12.8
6.7
2.9
0.1
−1.2
−0.5
Income tax $B
0.8
0.4
0.7
2.6
1.0
−0.1
0.3
−0.1
−0.2
Net income $B
2.3
0.7
1.3
7.7
3.2
0.5
1.0
3.6
0.3
EPS, diluted $
4.66
1.36
2.53
14.18
5.52
0.81
1.70
5.72
0.39
Dividend / sh $
·
2.16
2.12
1.92
·
·
·
·
·
Payout %
47
157
82
13
33
224
103
27
101
ROE %
9.1
2.7
4.9
31.0
13.7
2.1
·
·
·
Shares out B
·
0.49
0.49
0.51
0.56
0.57
0.57
0.61
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
27 of 36
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 9 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed